L & S Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,853
Closed -$1.58M 378
2024
Q1
$1.58M Sell
4,853
-1,031
-18% -$253K 0.18% 141
2023
Q4
$1.12M Buy
+5,884
New +$1.11M 0.14% 163
2023
Q3
Sell
-3,397
Closed -$970K 339
2023
Q2
$970K Buy
+3,397
New +$943K 0.13% 159
2023
Q1
Sell
-2,822
Closed -$580K 340
2022
Q4
$580K Sell
2,822
-2,869
-50% -$725K 0.11% 163
2022
Q3
$1.58M Sell
5,691
-1,995
-26% -$507K 0.28% 87
2022
Q2
$1.47M Sell
7,686
-2,726
-26% -$481K 0.25% 97
2022
Q1
$2.16M Buy
+10,412
New +$1.72M 0.26% 114

Other funds holding SWAV

L & S Advisors's SWAV Position: Q2 2024 in Review

L & S Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,853 shares — an estimated $1.58M sold.

L & S Advisors first reported a position in SWAV in Q1 2022 and held it in 7 quarters. The position peaked at $2.16M in Q1 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • L & S Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • L & S Advisors sold 4,853 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.58M.
  • L & S Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • L & S Advisors's Shockwave Medical, Inc. Common Stock position peaked at $2.16M in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on L & S Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.